| 产品详情 |
| Edit |   |
| Product Name | Recombinant Human CD19 Fc Chimera Protein, CF |
| Description | Purity >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 77-92 kDa, reducing conditions. MW (theoretical): 57 kDa. The Recombinant Human CD19 Fc Chimera Protein from R&D Systems is derived from CHO. The Recombinant Human CD19 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
| Size | 50 ug |
| Concentration | n/a |
| Applications | Bioactivity |
| Other Names | B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, Leu-12, MGC12802, T-cell surface antigen Leu-12 |
| Gene, Accession, CAS # | Gene ID: 930, Accession: P15391 |
| Catalog # | 9269-CD-050 |
| Price | |
| Order / More Info | Recombinant Human CD19 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|